It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by dgtempe
I think now the damage has been already done. I dont know many people who would trust these medicines again.
Wood said it is important to find some way to help the public better understand the nature of risk.
“People worry about crime and then drive drunk,” he said, indicating they don’t really understand relative risks.
Dr. Steven Nissen, medical director of the heart center at the Cleveland Clinic said, “What we really want is to make sure it’s available for patients that need it and is unavailable to patients for whom it’s inappropriate.”
Originally posted by GradyPhilpott
I'm not quite sure how drug companies became such villains, but I think many of us, myself included owe our lives to the drug companies and it is just a little asinine to portray them in the light that many prefer to do.
Prescriptions for these medications have already dropped more than 50% in the last five months.
There are some doctors who feel that the cox-2 inhibitors are not safe. Dr. Steven Rich, Chief of Internal Medicine at Lifetime Health did research three years ago, found the drugs were “not safe” and wrote a letter in the medical journal. At that time Dr. Rich recommended that all patients be taken off Vioxx and other drugs like it.
Regarding today's events, Rich said regardless of the FDA action, he thinks the class of medication is unsafe and unjustifiable for use by most patients.
Merck (MRK) surged 13 percent to $32.61 after the drugmaker's Vioxx received a Food and Drug Administration panel's backing at a hearing Thursday. The panel said that while Vioxx posed increased cardiovascular risks, it was safe to put on the market.
Merck said it would consider putting Vioxx back on the market if the FDA determines that similar drugs can also cause heart problems in certain patients. Merck withdrew Vioxx from the market in late September when it was linked to a higher incidence of heart attack and stroke.